Cargando…

Bone marrow adipoq(+) cell population controls bone mass via sclerostin in mice

Detalles Bibliográficos
Autores principales:	Gao, Huanqing, Zhong, Yiming, Lin, Sixiong, Yan, Qinnan, Zou, Xuenong, Xiao, Guozhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10330180/ https://www.ncbi.nlm.nih.gov/pubmed/37423945 http://dx.doi.org/10.1038/s41392-023-01461-0

Ejemplares similares

LIM domain proteins Pinch1/2 regulate chondrogenesis and bone mass in mice
por: Lei, Yiming, et al.
Publicado: (2020)

Osteocyte β1 integrin loss causes low bone mass and impairs bone mechanotransduction in mice
por: Qin, Lei, et al.
Publicado: (2022)

Sclerostin Depletion Induces Inflammation in the Bone Marrow of Mice
por: Donham, Cristine, et al.
Publicado: (2021)

Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice
por: Gao, Huanqing, et al.
Publicado: (2022)

Kindlin-2 mediates mechanotransduction in bone by regulating expression of Sclerostin in osteocytes
por: Qin, Lei, et al.
Publicado: (2021)

Bone marrow Adipoq-lineage progenitors are a major cellular source of M-CSF that dominates bone marrow macrophage development, osteoclastogenesis, and bone mass
por: Inoue, Kazuki, et al.
Publicado: (2023)

Loss of phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (Pip5k1c) in mesenchymal stem cells leads to osteopenia by impairing bone remodeling
por: Yan, Qinnan, et al.
Publicado: (2022)

Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression
por: Wei, Qiushi, et al.
Publicado: (2020)

Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression
por: Wei, Qiushi, et al.
Publicado: (2023)

Kindlin-2 inhibits TNF/NF-κB-Caspase 8 pathway in hepatocytes to maintain liver development and function
por: Gao, Huanqing, et al.
Publicado: (2023)

Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
por: Williams, Diarra K, et al.
Publicado: (2017)

Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms
por: Chen, Sheng, et al.
Publicado: (2022)

Brief research report: Effects of Pinch deficiency on cartilage homeostasis in adult mice
por: Wu, Xiaohao, et al.
Publicado: (2023)

The Role of Sclerostin in Bone Diseases
por: Vasiliadis, Elias S., et al.
Publicado: (2022)

Relationships between Circulating Sclerostin, Bone Marrow Adiposity, Other Adipose Deposits and Lean Mass in Post-Menopausal Women
por: Courtalin, Marion, et al.
Publicado: (2023)

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength of Intact Bones in Adult Male Rats
por: Suen, Pui Kit, et al.
Publicado: (2015)

Influence of Muscle Mass and Strength on Bone Mineralisation with Consideration of Sclerostin Concentration
por: Patalong-Wójcik, Martyna, et al.
Publicado: (2023)

Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis
por: Ueland, Thor, et al.
Publicado: (2019)

The Role of Sclerostin in Bone and Ectopic Calcification
por: De Maré, Annelies, et al.
Publicado: (2020)

Effects of sclerostin antibody on bone healing
por: Mihara, Atsushi, et al.
Publicado: (2021)

Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases
por: Chen, Lihui, et al.
Publicado: (2022)

Targeting Kindlin-2 in adipocytes increases bone mass through inhibiting FAS/PPARγ/FABP4 signaling in mice
por: Tang, Wanze, et al.
Publicado: (2023)

Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
por: Mödder, Ulrike I, et al.
Publicado: (2011)

Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
por: Stegen, Steve, et al.
Publicado: (2018)

Sclerostin expression in trabecular bone is downregulated by osteoclasts
por: Koide, Masanori, et al.
Publicado: (2020)

Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones
por: Wang, Jialiang S., et al.
Publicado: (2021)

Obesity and Bone Loss at Menopause: The Role of Sclerostin
por: Marzullo, Paolo, et al.
Publicado: (2021)

Importance of Sclerostin as Bone-Muscle Mediator Crosstalk
por: Aryana, I Gusti Putu Suka, et al.
Publicado: (2022)

Sclerostin: clinical insights in muscle–bone crosstalk
por: Moretti, Antimo, et al.
Publicado: (2023)

Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice
por: Liu, Wen, et al.
Publicado: (2019)

CHIP regulates bone mass by targeting multiple TRAF family members in bone marrow stromal cells
por: Wang, Tingyu, et al.
Publicado: (2018)

Bone and Bone Marrow Involvement in Sarcoidosis
por: Sargın, Gökhan, et al.
Publicado: (2014)

Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice
por: Fu, Xuekun, et al.
Publicado: (2020)

Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass
por: Gombos, Gabriella Császárné, et al.
Publicado: (2016)

Sclerostin as a novel marker of bone turnover in athletes
por: Zagrodna, A, et al.
Publicado: (2016)

Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement
por: Shu, Rui, et al.
Publicado: (2017)

Sclerostin expression in the subchondral bone of patients with knee osteoarthritis
por: Wu, Long, et al.
Publicado: (2016)

Sclerostin's role in bone's adaptive response to mechanical loading
por: Galea, Gabriel L, et al.
Publicado: (2017)

Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
por: Fabre, Stéphanie, et al.
Publicado: (2020)

The roles of sclerostin and irisin on bone and muscle of orchiectomized rats
por: Zhou, Bing-na, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_us0fmauqcdtfq3klins7me0jbu